Cancer Letters Journal Citation Rate 2026

ISSN 0304-3835 eISSN 1872-7980 Elsevier BV NL

Approx. Q1 Quartile Top Tier

About Cancer Letters
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer Letters (CL) is an academic journal covering Cancer, Hypoxia, and Metabolism and Cancer-related Molecular Pathways, published by Elsevier BV in NL, catalogued under ISSN 0304-3835 (e-ISSN 1872-7980). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 8.60 (approximate Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4100 USD). OpenAlex records 19,260 works and 802,446 citations, with an h-index of 269.

Cancer Letters Citation Rate 2026 — In Context

Cancer Letters has a 2025 2-Year Citation Rate (OpenAlex) of 8.60, placing it in the approximate Q1 quartile within the Cancer, Hypoxia, and Metabolism research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Cancer Letters operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Cancer Letters should review the journal's submission tips and check the latest indexing status at the source (the Scopus Sources list, DOAJ and Web of Science); our indexing tracker shows the OpenAlex and DOAJ coverage we hold. To compare Cancer Letters against similar journals in the field, use our journal comparison tool.

Submission Tips for Cancer Letters
  • Budget $4100 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Letters Compares
Citation Rate vs Field Avg
+209%
Field avg: 2.78
APC vs Field Avg
+21%
Field avg: $3399

Compared against 147 journals in the same research areas.

ISSN (Print) 0304-3835
ISSN (Online) 1872-7980
Publisher Elsevier BV
Country Netherlands
APC / Cost $4100 USD
h-index 282
Total Works 19,237
Total Citations 869,565
2-yr Mean Citedness 10.97 (OpenAlex)
In-depth profile & metrics

Cancer Letters is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4100.

In our subject taxonomy, Cancer Letters is classified under Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies and Human auditory perception and evaluation.

Cancer Letters is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 19,237 works that have together drawn 869,565 citations, giving the journal an h-index of 282; its most recent citation rate stands at 8.599; OpenAlex puts its two-year mean citedness at 10.97.

Research Areas
Links
Frequently Asked Questions about Cancer Letters

Cancer Letters does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 8.599 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Cancer Letters is not an open access journal.

The Article Processing Charge (APC) for Cancer Letters is $4100 USD.

Cancer Letters is published by Elsevier BV.

Cancer Letters appears in: OpenAlex. A listing is one signal of a legitimate journal, but it is not proof, and JournalsHub does not verify peer review. Always confirm the journal's peer-review policy, scope and editorial board before submitting.

The ISSN of Cancer Letters is 0304-3835. Its electronic ISSN (eISSN) is 1872-7980.

Cancer Letters sits in the Q1 quartile based on its latest impact factor of 8.60, ranked across all journals in our database.
OpenAlex and DOAJ Coverage
Updated April 2026

OpenAlex and DOAJ coverage we hold for this journal. Check other databases at the source.

OpenAlex
In OpenAlex
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
8.599
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 8.599 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex and DOAJ and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 598 56,506
2024 624 57,111
2023 378 54,034
2022 366 55,604
2021 474 56,405
2020 495 51,067
2019 480 42,070
2018 547 38,182
2017 509 37,100
2016 527 34,483
2015 489 33,357
2014 485 31,844
Journal at a Glance
19,237
Total Works
869,565
Total Citations
282
h-index
10.97
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Cancer Letters most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Carcinogens and Genotoxicity Assessment
Biochemistry, Genetics and Molecular Biology
2,268 works
1,425 works
1,291 works
Cell death mechanisms and regulation
Biochemistry, Genetics and Molecular Biology
1,028 works
Cancer-related molecular mechanisms research
Biochemistry, Genetics and Molecular Biology
863 works
Cancer and biochemical research
Biochemistry, Genetics and Molecular Biology
807 works
Bioactive Compounds and Antitumor Agents
Pharmacology, Toxicology and Pharmaceutics
800 works

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S106234763

Get weekly updates for Cancer, Hypoxia, and Metabolism journals

Free. Monday morning. New citation rates, CFPs, updates on journals you track, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google